Ladenburg Thalmann Financial Services’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
Other funds holding TCRT
MP
MVP
DCM
Ladenburg Thalmann Financial Services's TCRT Position: Q4 2019 in Review
Ladenburg Thalmann Financial Services increased its Alaunos Therapeutics (TCRT) stake by 4.8% in Q4 2019, buying an estimated $24.1K and bringing the position to 771 shares worth $545K. The position accounts for ﹤0.01% of the portfolio, ranked #1740.
Ladenburg Thalmann Financial Services first reported a position in TCRT in Q4 2014 and has held it in 21 quarters since. The position peaked at $643K in Q2 2019. 148 funds tracked by Wall St. Rank hold TCRT as of Q4 2019.
- Ladenburg Thalmann Financial Services held 771 shares of Alaunos Therapeutics worth $545K as of Q4 2019.
- Ladenburg Thalmann Financial Services bought 35 Alaunos Therapeutics shares in Q4 2019, an estimated $24.1K.
- Alaunos Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #1740 holding.
- Ladenburg Thalmann Financial Services first reported a position in Alaunos Therapeutics in Q4 2014 and has held it in 21 quarters since.
- Ladenburg Thalmann Financial Services's Alaunos Therapeutics position peaked at $643K in Q2 2019.
- 148 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.